Modification of proteins in vitro by physiological levels of glucose -: Pyridoxamine inhibits conversion of Amadori intermediate to advanced glycation end-products through binding of redox metal ions

被引:117
作者
Voziyan, PA
Khalifah, RG
Thibaudeau, C
Yildiz, A
Jacob, J
Serianni, AS
Hudson, BG
机构
[1] Vanderbilt Univ, Med Ctr, Dept Med, Div Nephrol, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Med Ctr, Dept Biochem, Nashville, TN 37232 USA
[3] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA
[4] BioStratum Inc, Durham, NC 27703 USA
关键词
D O I
10.1074/jbc.M307155200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Hyperglycemic conditions of diabetes accelerate protein modifications by glucose leading to the accumulation of advanced glycation end- products ( AGEs). We have investigated the conversion of protein- Amadori intermediate to protein- AGE and the mechanism of its inhibition by pyridoxamine ( PM), a potent AGE inhibitor that has been shown to prevent diabetic complications in animal models. During incubation of proteins with physiological diabetic concentrations of glucose, PM prevented the degradation of the protein glycation intermediate identified as fructosyllysine ( Amadori) by C-13 NMR using [ 2-C-13]- enriched glucose. Subsequent removal of glucose and PM led to conversion of protein-Amadori to AGE N-epsilon- carboxymethyllysine ( CML). We utilized this inhibition of post- Amadori reactions by PM to isolate protein- Amadori intermediate and to study the inhibitory effect of PM on its degradation to protein-CML. We first tested the hypothesis that PM blocks Amadori-to- CML conversion by interfering with the catalytic role of redox metal ions that are required for this glycoxidative reaction. Support for this hypothesis was obtained by examining structural analogs of PM in which its known bidentate metal ion binding sites were modified and by determining the effect of endogenous metal ions on PM inhibition. We also tested the alternative hypothesis that the inhibitory mechanism involves formation of covalent adducts between PM and protein-Amadori. However, our C-13 NMR studies demonstrated that PM does not react with the Amadori. Because the mechanism of interference with redox metal catalysis is operative under the conditions closely mimicking the diabetic state, it may contribute significantly to PM efficacy in preventing diabetic complications in vivo. Inhibition of protein- Amadori degradation by PM also provides a simple procedure for the isolation of protein-Amadori intermediate, prepared at physiological levels of glucose for relevancy, to study both the biological effects and the chemistry of post- Amadori pathways of AGE formation.
引用
收藏
页码:46616 / 46624
页数:9
相关论文
共 64 条
[1]   Molecular basis for a link between complement and the vascular complications of diabetes [J].
Acosta, J ;
Hettinga, J ;
Flückiger, R ;
Krumrei, N ;
Goldfine, A ;
Angarita, L ;
Halperin, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (10) :5450-5455
[2]  
AHMED MU, 1986, J BIOL CHEM, V261, P4889
[3]   The AGE inhibitor pyridoxamine inhibits lipemia and development of renal and vascular disease in Zucker obese rats [J].
Alderson, NL ;
Chachich, ME ;
Youssef, NN ;
Beattie, RJ ;
Nachtigal, M ;
Thorpe, SR ;
Baynes, JW .
KIDNEY INTERNATIONAL, 2003, 63 (06) :2123-2133
[4]   Role of oxidative stress in diabetic complications - A new perspective on an old paradigm [J].
Baynes, JW ;
Thorpe, SR .
DIABETES, 1999, 48 (01) :1-9
[5]   Thiamine pyrophosphate and pyridoxamine inhibit the formation of antigenic advanced glycation end-products: Comparison with aminoguanidine [J].
Booth, AA ;
Khalifah, RG ;
Hudson, BG .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 220 (01) :113-119
[6]   In vitro kinetic studies of formation of antigenic advanced glycation end products (AGEs) - Novel inhibition of post-Amadori glycation pathways [J].
Booth, AA ;
Khalifah, RG ;
Todd, P ;
Hudson, BG .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (09) :5430-5437
[7]   ADVANCED PROTEIN GLYCOSYLATION IN DIABETES AND AGING [J].
BROWNLEE, M .
ANNUAL REVIEW OF MEDICINE, 1995, 46 :223-234
[8]   AMINOGUANIDINE PREVENTS DIABETES-INDUCED ARTERIAL-WALL PROTEIN CROSS-LINKING [J].
BROWNLEE, M ;
VLASSARA, H ;
KOONEY, A ;
ULRICH, P ;
CERAMI, A .
SCIENCE, 1986, 232 (4758) :1629-1632
[9]   IN THE ABSENCE OF CATALYTIC METALS ASCORBATE DOES NOT AUTOXIDIZE AT PH-7 - ASCORBATE AS A TEST FOR CATALYTIC METALS [J].
BUETTNER, GR .
JOURNAL OF BIOCHEMICAL AND BIOPHYSICAL METHODS, 1988, 16 (01) :27-40
[10]   GLYCOSYLATION OF HEMOGLOBIN - RELEVANCE TO DIABETES-MELLITUS [J].
BUNN, HF ;
GABBAY, KH ;
GALLOP, PM .
SCIENCE, 1978, 200 (4337) :21-27